Remote Senior Director, Payor and Health Systems Liaison, West
Revolution Medicines, Inc. · Salt Lake City, UT
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. and RMC-5127, a RAS(ON) G12V-selective inhibitor, are cur...